guest ::
| Home > Publications database > Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. > print |
| Home > Publications database > Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. > print |
| 001 | 179697 | ||
| 005 | 20240229145551.0 | ||
| 024 | 7 | _ | |a 10.1038/s43018-022-00353-6 |2 doi |
| 024 | 7 | _ | |a pmid:35469015 |2 pmid |
| 024 | 7 | _ | |a altmetric:127275271 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2022-00846 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hongu, Tsunaki |0 P:(DE-He78)876d213ee6559a5e98ddf2113698ed0b |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. |
| 260 | _ | _ | |a London |c 2022 |b Nature Research |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1651590717_6243 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a #EA:A010#LA:A010# / 2022 Apr;3(4):486-504 |
| 520 | _ | _ | |a Disseminated cancer cells frequently lodge near vasculature in secondary organs. However, our understanding of the cellular crosstalk invoked at perivascular sites is still rudimentary. Here, we identify intercellular machinery governing formation of a pro-metastatic vascular niche during breast cancer colonization in the lung. We show that specific secreted factors, induced in metastasis-associated endothelial cells (ECs), promote metastasis in mice by enhancing stem cell properties and the viability of cancer cells. Perivascular macrophages, activated via tenascin C (TNC) stimulation of Toll-like receptor 4 (TLR4), were shown to be crucial in niche activation by secreting nitric oxide (NO) and tumor necrosis factor (TNF) to induce EC-mediated production of niche components. Notably, this mechanism was independent of vascular endothelial growth factor (VEGF), a key regulator of EC behavior and angiogenesis. However, targeting both macrophage-mediated vascular niche activation and VEGF-regulated angiogenesis resulted in added potency to curb lung metastasis in mice. Together, our findings provide mechanistic insights into the formation of vascular niches in metastasis. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 700 | 1 | _ | |a Pein, Maren |0 P:(DE-He78)857b9409476ae7e0ab904637e739f88b |b 1 |
| 700 | 1 | _ | |a Insua-Rodríguez, Jacob |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Gutjahr, Ewgenija |b 3 |
| 700 | 1 | _ | |a Mattavelli, Greta |b 4 |
| 700 | 1 | _ | |a Meier, Jasmin |0 P:(DE-He78)5b11915b010a335eea3bb6401fdadb1f |b 5 |u dkfz |
| 700 | 1 | _ | |a Decker, Kristin |0 P:(DE-He78)c0ef7f4dc2506a8556df9214b1b713ba |b 6 |
| 700 | 1 | _ | |a Descot, Arnaud |0 P:(DE-He78)2a2525a03e926ea91ee9ac423bc8c7ba |b 7 |
| 700 | 1 | _ | |a Bozza, Matthias |0 P:(DE-He78)3391c5ad790ea5359189d11f073fb103 |b 8 |u dkfz |
| 700 | 1 | _ | |a Harbottle, Richard |0 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62 |b 9 |u dkfz |
| 700 | 1 | _ | |a Trumpp, Andreas |0 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2 |b 10 |u dkfz |
| 700 | 1 | _ | |a Sinn, Hans-Peter |0 0000-0003-2836-6699 |b 11 |
| 700 | 1 | _ | |a Riedel, Angela |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Oskarsson, Thordur |0 P:(DE-He78)ee36a00803235200292c3488043cfd68 |b 13 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s43018-022-00353-6 |0 PERI:(DE-600)3005299-3 |n 4 |p 486-504 |t Nature cancer |v 3 |y 2022 |x 2662-1347 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:179697 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)876d213ee6559a5e98ddf2113698ed0b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)857b9409476ae7e0ab904637e739f88b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)5b11915b010a335eea3bb6401fdadb1f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)c0ef7f4dc2506a8556df9214b1b713ba |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)2a2525a03e926ea91ee9ac423bc8c7ba |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)3391c5ad790ea5359189d11f073fb103 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)15dff5647002b4dcfe892b251cd14b62 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)732f4fbcddb0042251aa759a2e74d3b2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)ee36a00803235200292c3488043cfd68 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NAT CANCER : 2021 |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-08 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-08 |
| 915 | _ | _ | |a IF >= 20 |0 StatID:(DE-HGF)9920 |2 StatID |b NAT CANCER : 2021 |d 2022-11-08 |
| 920 | 2 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)F160-20160331 |k F160 |l F160 DNA-Vektoren |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)HD01-20160331 |k HD01 |l DKTK HD zentral |x 2 |
| 920 | 0 | _ | |0 I:(DE-He78)A010-20160331 |k A010 |l A010 Stammzellen und Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A010-20160331 |
| 980 | _ | _ | |a I:(DE-He78)F160-20160331 |
| 980 | _ | _ | |a I:(DE-He78)HD01-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|